ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RENE Reneuron Group Plc

3.05
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.05 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 530k -5.41M -0.0946 -0.32 1.74M
Reneuron Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker RENE. The last closing price for Reneuron was 3.05p. Over the last year, Reneuron shares have traded in a share price range of 2.95p to 10.25p.

Reneuron currently has 57,173,760 shares in issue. The market capitalisation of Reneuron is £1.74 million. Reneuron has a price to earnings ratio (PE ratio) of -0.32.

Reneuron Share Discussion Threads

Showing 4451 to 4474 of 8900 messages
Chat Pages: Latest  188  187  186  185  184  183  182  181  180  179  178  177  Older
DateSubjectAuthorDiscuss
18/5/2015
12:22
Yes this could drop back a bit for those who want to get in.
madengland
18/5/2015
11:50
Can we tell if Tosca have gradually fed their shares into the market or sold them in one batch? I guess the share price will drift until we know where the 5% has gone.
verger
15/5/2015
14:44
Just managed to fit in a brain transplant today so I'm fine now thanks!
verger
15/5/2015
09:02
I think you'll find the current term for what you may have experienced is a "brain fade". Two have reliably been reported by scentists in recent months, and you might be able to claim the third ;-)
small crow
15/5/2015
08:59
Mis-read the rns I guess partly because I wasn't expecting Toscafund to be selling out. I though Reneuron was just the kind of company Tosca liked - huge potential multibagger etc. Let's see who has bought the shares.
verger
15/5/2015
08:12
Wouldn't think it were Woodford. He's not t/o potential? Just looking for a large gain, like the rest of us. 😎
rayrac
15/5/2015
08:07
Almost certainly Woodford...already owns it in his main fund and will need a position in Patient Capital too. I'd have thought he'll go up to 29.9%
konkel
15/5/2015
07:52
Well that's who's out..... Who's in?
madengland
15/5/2015
07:42
Verger the notification says they sold all 97,412,471
square1
15/5/2015
07:39
The Woodford Fund could be an interesting place for long term cash. Large holder of TRX also!
rayrac
15/5/2015
07:36
Square1, if Toscafund had more than 5% why didn't they appear on the Reneuron site as a major holder? How many shares do you reckon they have sold?
verger
15/5/2015
07:34
5%, probably into eager hands!
rayrac
15/5/2015
07:28
Tosca sold not increased- we await the buyers identity
square1
15/5/2015
07:26
So it is Toscafund. They have patiently held onto their shares and are now increasing. Onwards and upwards.
verger
14/5/2015
17:34
Come on Rene tell us who bought all those shares?
madengland
14/5/2015
15:23
Looks like a clear break out.
deltar
14/5/2015
11:10
Be nice to see who the new major holders are, guess notifications soon
madengland
13/5/2015
17:29
Lot of big and probably new positions being taken here
bigspuds
13/5/2015
11:32
The good news is the vote of confidence in the efficacy ; greast if the stroke treatment works
norbus
13/5/2015
11:14
Someone does not buy 10% of a co pant like this on a whim. Strategic stake? Another fund or Woodford? Guess we will know soon who's buying. Looks to be one of Zak's more sustainable picks from today
madengland
13/5/2015
11:12
I wonder, the PISCES trial has now evolved to a full dose due to the excellent safety record. Could results be leaking out? Am far from an expert in this area, anyone know more about the way trials are conducted and information managed?
madengland
13/5/2015
10:55
So Zak says 7.5p then
madengland
13/5/2015
08:24
would be good if it was - would show extreme confidence in this and bolster the share price a lot i would imagine...
stewart_25
13/5/2015
07:28
Surely not Woodford taking another 10%
madengland
Chat Pages: Latest  188  187  186  185  184  183  182  181  180  179  178  177  Older